Latest News

Tonix’s stock jumps 43% on patent for experimental pox vaccines


Shares of Tonix Pharmaceuticals Holding Corp.

gained 43.8% in premarket trading on Wednesday after the company said the U.S. Patent and Trademark Office issued a patent to the company’s poxvirus vaccine and its recombinant poxvirus platform. The horsepox-based live virus vaccine is being developed against monkeypox and smallpox. The patent gives the company market exclusivity until 2037. Tonix’s stock has tumbled 78.7% so far this year, while the S&P 500

is down 13.3%.

Microsoft revamps its budget Surface Laptop Go with more storage

Previous article

Apple will reportedly move some iPad capacity to Vietnam after China lockdowns

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News